Systematic review with meta-analysis: Post-infectious irritable bowel syndrome after travellers' diarrhoea

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 11, 2015, Pages 1029-1037

  Schwille Kiuntke, J ^a   Mazurak, N ^a,b   Enck, P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b SymbioPharm GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANXIETY; DEPRESSION; DISEASE ASSOCIATION; HUMAN; INCIDENCE; IRRITABLE COLON; NONHUMAN; POSTINFECTIOUS IRRITABLE BOWEL SYNDROME; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; SYSTEMATIC REVIEW; TRAVELLER DIARRHEA; VIRAL GASTROENTERITIS; COMPLICATION; DIARRHEA; GASTRITIS; IRRITABLE BOWEL SYNDROME; META ANALYSIS; TRAVEL;

DIARRHEA; GASTRITIS; HUMANS; INCIDENCE; IRRITABLE BOWEL SYNDROME; RISK FACTORS; TRAVEL;

EID: 84929133994     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13199     Document Type: Review

References (63)

1. Saito YA, Schoenfeld P, Locke GR 3rd,. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002; 97: 1910-5.
2. Gwee KA,. Irritable bowel syndrome in developing countries-a disorder of civilization or colonization? Neurogastroenterol Motil 2005; 17: 317-24.
3. Canavan C, West J, Card T,. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014; 40: 1023-34.
4. Agarwal N, Spiegel BM,. The effect of irritable bowel syndrome on health-related quality of life and health care expenditures. Gastroenterol Clin North Am 2011; 40: 11-9.
5. Saito YA, Petersen GM, Locke GR 3rd, Talley NJ,. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol 2005; 3: 1057-65.
6. Camilleri M,. Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics. Dig Dis Sci 2009; 54: 2318-24.
7. Saito YA, Mitra N, Mayer EA,. Genetic approaches to functional gastrointestinal disorders. Gastroenterology 2010; 138: 1276-85.
8. Chaudhary NA, Truelove SC,. The irritable colon syndrome: a study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med 1962; 31: 307-22.
9. Barbara G, Cremon C, Pallotti F, De Giorgio R, Stanghellini V, Corinaldesi R,. Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr 2009; 48 (Suppl. 2): S95-7.
10. DuPont AW,. Postinfectious irritable bowel syndrome. Clin Infect Dis 2008; 46: 594-9.
11. Schwille-Kiuntke J, Unverdorben A, Weimer K, et al,. Bacterial infections in childhood-a risk factor for gastrointestinal and other diseases? United European Gastroenterol J 2015; 3: 31-8.
12. Futagami S, Itoh T, Sakamoto C,. Systematic review: post-infectious functional dyspepsia. Aliment Pharmacol Ther 2015; 41: 177-88.
13. Marshall JK, Thabane M, Garg AX, et al,. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010; 59: 605-11.
14. Stermer E, Lubezky A, Potasman I, Paster E, Lavy A,. Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study Clin lnfect Dis 2006; 43: 898-901.
15. Rodriguez LA, Ruigomez A,. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 1999; 318: 565-6.
16. Schwille-Kiuntke J, Frick J-S, Zanger P, Enck P,. Post-infectious irritable bowel syndrome-a review of the literature. Z Gastroenterol 2011; 49: 997-1003.
17. Stang A,. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-5.
18. Landis JR, Koch GG,. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
19. Kisamore JL, Brannick MT,. An Illustration of the Consequences of Meta-Analysis Model Choice. Organ Res Methods 2008; 11: 35-53.
20. Davies HT, Crombie IK, Tavakoli M,. When can odds ratios mislead? BMJ 1998; 316: 989-91.
21. Higgins JPT,. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 2008; 37: 1158-60.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
23. Ried K,. Interpreting and understanding meta-analysis graphs-a practical guide. Aust Fam Physician 2006; 35: 635-8.
24. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
25. Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
26. Leder K, Torresi J, Libman M, et al,. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med 2013; 158: 456-68.
27. Harvey K, Esposito D, Han P, et al,. Surveillance for travel-related disease-GeoSentinel Surveillance System, United States, 1997-2011. MMWR Surveill Summ 2013; 62: 1-23.
28. Porter C, Gloor K, Cash B, Riddle M,. Risk of functional gastrointestinal disorders in U.S. military following self-reported diarrhea and vomiting during deployment. Dig Dis Sci 2011; 56: 3262-9.
29. Ilnyckyj A, Balachandra B, Elliott L, Choudhri S, Duerksen DR,. Post-traveler's diarrhea irritable bowel syndrome: a prospective study. Am J Gastroenterol 2003; 98: 596-9.
30. Tuteja AK, Talley NJ, Gelman SS, et al,. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci 2008; 53: 271-6.
31. Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL,. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 2004; 99: 1774-8.
32. Trivedi KH, Schlett CD, Tribble DR, Monteville MR, Sanders JW, Riddle MS,. The impact of post-infectious functional gastrointestinal disorders and symptoms on the health-related quality of life of US military personnel returning from deployment to the Middle East. Dig Dis Sci 2011; 56: 3602-9.
33. Pitzurra R, Fried M, Rogler G, et al,. Irritable bowel syndrome among a cohort of European travelers to resource-limited destinations. J Travel Med 2011; 18: 250-6.
34. Nair P, Okhuysen PC, Jiang ZD, et al,. Persistent abdominal symptoms in US adults after short-term stay in Mexico. J Travel Med 2014; 21: 153-8.
35. Lalani T, Maguire J, Grant E, et al,. Epidemiology and self-treatment of travelers' diarrhea in a large, prospective cohort of department of defense beneficiaries. J Travel Med 2014; doi: 10.1111/jtm.12179 [Epub ahead of print]
36. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-12.
37. Thabane M, Kottachchi DT, Marshall JK,. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26: 535-44.
38. Halvorson HA, Schlett CD, Riddle MS,. Postinfectious irritable bowel syndrome-a meta-analysis. Am J Gastroenterol 2006; 101: 1894-9.
39. Baillargeon J,. Characteristics of the healthy worker effect. Occup Med 2001; 16: 359-66.
40. Marshall JK, Thabane M, Garg AX, et al,. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006; 131: 445-50.
41. Dunlop SP, Jenkins D, Neal KR, Spiller RC,. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003; 125: 1651-9.
42. Gwee KA, Graham JC, McKendrick MW, et al,. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-3.
43. Hu WH, Wong WM, Lam CL, et al,. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther 2002; 16: 2081-8.
44. Parry SD, Stansfield R, Jelley D, et al,. Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study. Am J Gastroenterol 2003; 98: 327-31.
45. Boyce PM, Koloski NA, Talley NJ,. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000; 95: 3176-83.
46. Mearin F, Badia X, Balboa A, et al,. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001; 36: 1155-61.
47. Marshall JK, Thabane M, Borgaonkar MR, James C,. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol 2007; 5: 457-60.
48. Zanini B, Ricci C, Bandera F, et al,. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol 2012; 107: 891-9.
49. Qadri F, Svennerholm AM, Faruque AS, Sack RB,. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 2005; 18: 465-83.
50. Jimenez-Gonzalez DE, Martinez-Flores WA, Reyes-Gordillo J, et al,. Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res 2012; 110: 1269-75.
51. Stensvold CR, Lewis HC, Hammerum AM, et al,. Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite. Epidemiol Infect 2009; 137: 1655-63.
52. Hanevik K, Dizdar V, Langeland N, Hausken T,. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol 2009; 9: 27.
53. Borody TJ, Warren EF, Wettstein A, et al,. Eradication of Dientamoeba fragilis can resolve IBS-like symptoms. J Gastroenterol Hepatol 2002; 17 (Suppl.): A103.
54. Grover M, Camilleri M, Smith K, Linden DR, Farrugia G,. On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens. Neurogastroenterol Motil 2014; 26: 156-67.
55. Ji S, Park H, Lee D, Song YK, Choi JP, Lee SI,. Post-infectious irritable bowel syndrome in patients with Shigella infection. J Gastroenterol Hepatol 2005; 20: 381-6.
56. Thabane M, Simunovic M, Akhtar-Danesh N, et al,. An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am J Gastroenterol 2010; 105: 933-9.
57. Ruigomez A, Wallander MA, Johansson S, Garcia Rodriguez LA,. One-year follow-up of newly diagnosed irritable bowel syndrome patients. Aliment Pharmacol Ther 1999; 13: 1097-102.
58. Spiller R, Garsed K,. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-88.
59. Schwille-Kiuntke J, Enck P, Zendler C, et al,. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil 2011; 23: e479-88.
60. Sperber A, Dekel R,. Irritable bowel syndrome and co-morbid gastrointestinal and extra-gastrointestinal functional syndromes. J Neurogastroenterol Motil 2010; 16: 113-9.
61. Spreadbury I, Ochoa-Cortes F, Ibeakanma C, Martin N, Hurlbut D, Vanner S,. Concurrent psychological stress and infectious colitis is key to sustaining enhanced peripheral sensory signaling. Neurogastroenterol Motil 2015; 27: 347-55.
62. Sundin J, Rangel I, Fuentes S, et al,. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress. Aliment Pharmacol Ther 2015; 41: 342-51.
63. Scherer R, Langenberg P, Von Elm E,. Full publication of results initially presented in abstracts. Cochrane Database Syst Rev 2007; 18: MR000005.